Lululemon Athletica
LULU
91.88
-1.73
-1.85%
Lululemon Athletica
US · LULU
#1433 by market cap
Listed 1970
91.88
-1.73
-1.85%
Live - 5344 symbols - heartbeat 18s ago
· 2026-10-08 07:48
Pre-market
91.30
-0.63%
After-hours
91.79
-0.10%
Overnight
91.39
-0.53%
- Market cap
- 10.17B
- P/E (TTM)i
- 7.56
- P/Bi
- 2.12
- EPSi
- 13.26
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on LULU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.01, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.86% YoY
Margins
- Gross margin
- 56.60%
- Operating margin
- 19.91%
- Net margin
- 14.22%
Key ratios & quality
- PEG ratioi
- 0.33
- Altman Z-Scorei
- 5.01
PEG uses trailing P/E against the 3-year net income growth rate (22.70%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.29B | 3.98B | 4.40B | 6.26B | 8.11B | 9.62B | 10.59B | 11.10B |
| Gross profit | 1.82B | 2.22B | 2.46B | 3.61B | 4.49B | 5.61B | 6.27B | 6.28B |
| Selling & admin expenses | 1.11B | 1.33B | 1.61B | 2.23B | 2.76B | 3.40B | 3.76B | 4.07B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 705.84M | 889.11M | 849.83M | 1.37B | 1.73B | 2.21B | 2.51B | 2.21B |
| Pretax profit | 715.25M | 897.39M | 819.35M | 1.33B | 1.33B | 2.18B | 2.58B | 2.24B |
| Tax | 231.45M | 251.80M | 230.44M | 358.55M | 477.77M | 625.55M | 761.46M | 659.78M |
| Net profit | 483.80M | 645.60M | 588.91M | 975.32M | 854.80M | 1.55B | 1.81B | 1.58B |
| Basic EPS | 4 | 5 | 5 | 8 | 7 | 12 | 15 | 13 |
| Diluted EPS | 3.61 | 4.93 | 4.50 | 7.49 | 6.68 | 12.20 | 14.64 | 13.26 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 2.37B | 2.53B | 2.57B | 3.64B | 2.47B | 2.42B |
| Gross profit | 1.38B | 1.48B | 1.43B | 2.00B | 1.34B | 1.46B |
| Selling & admin expenses | 942.87M | 951.66M | 988.25M | 1.18B | 1.06B | 1.01B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 438.63M | 523.81M | 435.89M | 812.29M | 276.95M | 453.65M |
| Pretax profit | 450.41M | 533.55M | 441.74M | 813.27M | 286.08M | 467.35M |
| Tax | 135.84M | 162.65M | 134.91M | 226.39M | 91.03M | 138.13M |
| Net profit | 314.57M | 370.91M | 306.84M | 586.87M | 195.05M | 329.22M |
| Basic EPS | 3 | 3 | 3 | 5 | 2 | 3 |
| Diluted EPS | 2.60 | 3.10 | 2.59 | 5.01 | 1.69 | 2.92 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.43B | 1.81B | 2.12B | 2.61B | 3.16B | 4.06B | 3.98B | 4.26B |
| Cash & ST investments | 881.32M | 1.09B | 1.15B | 1.26B | 1.15B | 2.24B | 1.98B | 1.81B |
| Inventory | 404.84M | 518.51M | 647.23M | 966.48M | 1.45B | 1.32B | 1.44B | 1.70B |
| Total assets | 2.08B | 3.28B | 4.19B | 4.94B | 5.61B | 7.09B | 7.60B | 8.46B |
| Total current liabilities | 500.48M | 620.42M | 883.18M | 1.41B | 1.49B | 1.63B | 1.84B | 1.89B |
| Short-term debt | -- | 128.50M | 166.09M | 189.00M | 207.97M | 249.27M | 275.15M | 298.72M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 638,736,000.00 | 1,329,136,000.00 | 1,626,649,000.00 | 2,202,432,000.00 | 2,458,239,000.00 | 2,859,860,000.00 | 3,279,245,000.00 | 3,494,903,000.00 |
| Total equity | 1.45B | 1.95B | 2.56B | 2.74B | 3.15B | 4.23B | 4.32B | 4.96B |
| Retained earnings | 1.35B | 1.82B | 2.35B | 2.51B | 2.93B | 3.92B | 4.11B | 4.52B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 3.58B | 3.53B | 3.92B | 4.26B | 3.99B | 3.95B |
| Cash & ST investments | 1.33B | 1.16B | 1.04B | 1.81B | 1.51B | 1.39B |
| Inventory | 1.65B | 1.72B | 2.00B | 1.70B | 1.69B | 1.71B |
| Total assets | 7.43B | 7.52B | 7.96B | 8.46B | 8.53B | 8.48B |
| Total current liabilities | 1.57B | 1.56B | 1.84B | 1.89B | 1.79B | 1.80B |
| Short-term debt | 281.84M | 297.92M | 317.48M | 298.72M | 357.20M | 366.65M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 3,140,973,000.00 | 3,136,160,000.00 | 3,453,169,000.00 | 3,494,903,000.00 | 3,705,840,000.00 | 3,693,404,000.00 |
| Total equity | 4.29B | 4.39B | 4.50B | 4.96B | 4.83B | 4.79B |
| Retained earnings | 3.99B | 4.09B | 4.20B | 4.52B | 4.36B | 4.36B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 742.78M | 669.32M | 803.34M | 1.39B | 966.46M | 2.30B | 2.27B | 1.60B |
| Depreciation & amortization | 122.48M | 161.93M | 185.48M | 224.21M | 291.79M | 379.38M | 446.52M | 496.23M |
| Free cash flow | 516.97M | 386.27M | 574.11M | 994.61M | 327.81M | 1.64B | 1.58B | 921.68M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -598.34M | -173.40M | -63.66M | -812.60M | -444.00M | -558.65M | -1.64B | -1.18B |
| Ending cash balance | 881.32M | 1.09B | 1.15B | 1.26B | 1.15B | 2.24B | 1.98B | 1.81B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | -118.95M | 328.68M | 249.88M | 1.14B | 214.44M | 374.84M |
| Depreciation & amortization | 114.53M | 119.72M | 127.46M | 134.53M | 135.34M | 142.33M |
| Free cash flow | -271.22M | 150.78M | 82.44M | 959.67M | 87.06M | 225.16M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -434.44M | -281.23M | -190.91M | -271.77M | -361.76M | -333.35M |
| Ending cash balance | 1.33B | 1.16B | 1.04B | 1.81B | 1.51B | 1.39B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 31.80 | 38.00 | 26.11 | 36.81 | 29.03 | 42.01 | 42.42 | 34.01 |
| ROA %i | 23.70 | 24.06 | 15.77 | 21.37 | 16.21 | 24.41 | 24.70 | 19.67 |
| ROIC %i | 31.80 | 26.47 | 19.47 | 27.95 | 21.81 | 31.46 | 31.46 | 24.95 |
| 5-year avg ROE %i | 24.34 | 27.57 | 27.76 | 30.04 | 32.35 | 34.39 | 35.28 | 36.86 |
| EBIT margin %i | 21.46 | 22.34 | 19.31 | 21.97 | 21.28 | 22.95 | 23.67 | 19.91 |
| FCF / sales %i | 15.72 | 9.71 | 13.04 | 15.90 | 4.04 | 17.09 | 14.96 | 8.30 |
| Current ratioi | 2.86 | 2.91 | 2.41 | 1.86 | 2.12 | 2.49 | 2.16 | 2.26 |
| Quick ratioi | 1.93 | 1.96 | 1.53 | 1.04 | 0.99 | 1.56 | 1.24 | 1.25 |
| Debt / assetsi | 0.00 | 22.55 | 19.08 | 17.83 | 19.09 | 19.79 | 20.73 | 21.27 |
| LT debt / equityi | -- | 31.32 | 24.72 | 25.26 | 27.39 | 27.27 | 30.08 | 30.23 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 16.86 | 19.29 | 18.44 | 23.91 | 26.79 | 29.77 | 19.17 | 11.03 |
| Net income CAGR (3Y) %i | 22.06 | 28.62 | 31.55 | 26.33 | 9.81 | 38.07 | 22.99 | 22.70 |
| FCF CAGR (3Y) %i | 49.72 | 17.70 | 20.09 | 24.37 | -5.32 | 42.01 | 16.77 | 41.14 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 42.49 | 42.42 | 41.02 | 34.01 | 32.03 | 30.90 |
| ROA %i | 25.36 | 25.03 | 23.15 | 19.67 | 18.29 | 17.72 |
| ROIC %i | 31.12 | 30.68 | 29.59 | 24.95 | 22.53 | 21.68 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 23.36 | 22.88 | 22.04 | 19.91 | 18.29 | 17.84 |
| FCF / sales %i | 12.24 | 10.71 | 10.19 | 8.30 | 11.42 | 12.21 |
| Current ratioi | 2.28 | 2.27 | 2.13 | 2.26 | 2.23 | 2.19 |
| Quick ratioi | 1.08 | 1.04 | 0.93 | 1.25 | 1.17 | 1.13 |
| Debt / assetsi | 22.97 | 23.43 | 22.16 | 21.27 | 25.04 | 25.24 |
| LT debt / equityi | 33.22 | 33.39 | 32.10 | 30.23 | 36.86 | 37.04 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:48:48 · For reference only, not investment advice and not tailored to your situation.